Similar articles for PMID: 24666523

Year	Number of Results
1995	1
1996	2
2001	2
2003	3
2004	4
2005	1
2006	3
2007	3
2008	10
2009	11
2010	6
2011	4
2012	9
2013	9
2014	10
2015	8
2016	5
2017	6
2018	7
2019	7
2020	6
2021	5
2024	0

1

Genetic polymorphisms modify bladder cancer recurrence and survival in a USA population-based prognostic study.

Andrew AS, Gui J, Hu T, Wyszynski A, Marsit CJ, Kelsey KT, Schned AR, Tanyos SA, Pendleton EM, Ekstrom RM, Li Z, Zens MS, Borsuk M, Moore JH, Karagas MR. Andrew AS, et al. BJU Int. 2015 Feb;115(2):238-47. doi: 10.1111/bju.12641. Epub 2014 Mar 26. BJU Int. 2015. PMID: 24666523 Free PMC article.

2

Outcome after BCG treatment for urinary bladder cancer may be influenced by polymorphisms in the NOS2 and NOS3 genes.

Ryk C, Koskela LR, Thiel T, Wiklund NP, Steineck G, Schumacher MC, de Verdier PJ. Ryk C, et al. Redox Biol. 2015 Dec;6:272-277. doi: 10.1016/j.redox.2015.08.008. Epub 2015 Aug 10. Redox Biol. 2015. PMID: 26298202 Free PMC article.

3

Single nucleotide polymorphisms in DNA repair genes might be prognostic factors in muscle-invasive bladder cancer patients treated with chemoradiotherapy.

Sakano S, Wada T, Matsumoto H, Sugiyama S, Inoue R, Eguchi S, Ito H, Ohmi C, Matsuyama H, Naito K. Sakano S, et al. Br J Cancer. 2006 Sep 4;95(5):561-70. doi: 10.1038/sj.bjc.6603290. Epub 2006 Aug 1. Br J Cancer. 2006. PMID: 16880786 Free PMC article.

4

The predictive value of GSTT1 polymorphisms in predicting the early response to induction BCG therapy in patients with non-muscle invasive bladder cancer.

Kang HW, Tchey DU, Yan C, Kim WT, Kim YJ, Yun SJ, Lee SC, Choi YH, Kim IY, Kim WJ. Kang HW, et al. Urol Oncol. 2014 May;32(4):458-65. doi: 10.1016/j.urolonc.2013.10.013. Epub 2014 Jan 9. Urol Oncol. 2014. PMID: 24411789

5

Genetic variations in the sonic hedgehog pathway affect clinical outcomes in non-muscle-invasive bladder cancer.

Chen M, Hildebrandt MA, Clague J, Kamat AM, Picornell A, Chang J, Zhang X, Izzo J, Yang H, Lin J, Gu J, Chanock S, Kogevinas M, Rothman N, Silverman DT, Garcia-Closas M, Grossman HB, Dinney CP, Malats N, Wu X. Chen M, et al. Cancer Prev Res (Phila). 2010 Oct;3(10):1235-45. doi: 10.1158/1940-6207.CAPR-10-0035. Epub 2010 Sep 21. Cancer Prev Res (Phila). 2010. PMID: 20858759 Free PMC article.

6

Nitric oxide synthase (eNOS4a/b) gene polymorphism is associated with tumor recurrence and progression in superficial bladder cancer cases.

Amasyali AS, Kucukgergin C, Erdem S, Sanli O, Seckin S, Nane I. Amasyali AS, et al. J Urol. 2012 Dec;188(6):2398-403. doi: 10.1016/j.juro.2012.07.096. Epub 2012 Oct 22. J Urol. 2012. PMID: 23088972

7

Nucleotide excision repair gene polymorphisms and recurrence after treatment for superficial bladder cancer.

Gu J, Zhao H, Dinney CP, Zhu Y, Leibovici D, Bermejo CE, Grossman HB, Wu X. Gu J, et al. Clin Cancer Res. 2005 Feb 15;11(4):1408-15. doi: 10.1158/1078-0432.CCR-04-1101. Clin Cancer Res. 2005. PMID: 15746040

8

Polymorphisms in the XRCC1 gene modify survival of bladder cancer patients treated with chemotherapy.

Sacerdote C, Guarrera S, Ricceri F, Pardini B, Polidoro S, Allione A, Critelli R, Russo A, Andrew AS, Ye Y, Wu X, Kiemeney LA, Bosio A, Casetta G, Cucchiarale G, Destefanis P, Gontero P, Rolle L, Zitella A, Fontana D, Vineis P, Matullo G. Sacerdote C, et al. Int J Cancer. 2013 Oct 15;133(8):2004-9. doi: 10.1002/ijc.28186. Epub 2013 Apr 25. Int J Cancer. 2013. PMID: 23553206 Free PMC article.

9

Polymorphism within the cyclin D1 gene is associated with an increased risk of carcinoma in situ in patients with superficial bladder cancer.

Ito M, Habuchi T, Watanabe J, Higashi S, Nishiyama H, Wang L, Tsuchiya N, Kamoto T, Ogawa O. Ito M, et al. Urology. 2004 Jul;64(1):74-8. doi: 10.1016/j.urology.2004.03.001. Urology. 2004. PMID: 15245939

10

Impact of nucleotide excision repair ERCC2 and base excision repair APEX1 genes polymorphism and its association with recurrence after adjuvant BCG immunotherapy in bladder cancer patients of North India.

Gangawar R, Ahirwar D, Mandhani A, Mittal RD. Gangawar R, et al. Med Oncol. 2010 Jun;27(2):159-66. doi: 10.1007/s12032-009-9187-y. Epub 2009 Feb 26. Med Oncol. 2010. PMID: 19242824

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

101 results

Results by year